These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 36484489)

  • 1. Distraction arthroplasty combined with autologous bone grafting for diffuse-type tenosynovial giant cell tumour with articular cartilage defect and subchondral bone cysts: A case report.
    Ikuta Y; Nakasa T; Sumii J; Nekomoto A; Kawabata S; Adachi N
    Mod Rheumatol Case Rep; 2023 Jun; 7(2):483-487. PubMed ID: 36484489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of tenosynovial giant cell tumour of the foot and ankle.
    Spierenburg G; Lancaster ST; van der Heijden L; Mastboom MJL; Gelderblom H; Pratap S; van de Sande MAJ; Gibbons CLMH
    Bone Joint J; 2021 Apr; 103-B(4):788-794. PubMed ID: 33789469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical treatment for diffused-type giant cell tumor (pigmented villonodular synovitis) about the ankle joint.
    Li X; Xu Y; Zhu Y; Xu X
    BMC Musculoskelet Disord; 2017 Nov; 18(1):450. PubMed ID: 29137617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct extra-articular invasion patterns of diffuse pigmented villonodular synovitis/tenosynovial giant cell tumor in the knee joints.
    Kim DE; Kim JM; Lee BS; Kim NK; Lee SH; Bin SI
    Knee Surg Sports Traumatol Arthrosc; 2018 Nov; 26(11):3508-3514. PubMed ID: 29637236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extensile Anterior and Posterior Knee Exposure for Complete Synovectomy of Diffuse Tenosynovial Giant Cell Tumor (Pigmented Villonodular Synovitis).
    Lingamfelter M; Novaczyk ZB; Cheng EY
    JBJS Essent Surg Tech; 2022; 12(2):. PubMed ID: 36741035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of Tenosynovial Giant Cell Tumor of the Foot and Ankle.
    Barnett JR; Rudran B; Khan A; O'Reilly-Harbidge S; Patel S; Malhotra K; Cullen N; Welck M; Aston W
    Foot Ankle Int; 2023 Oct; 44(10):1013-1020. PubMed ID: 37644900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of autologous bone grafting with preservation of articular cartilage to treat osteochondral lesions of the talus with large associated subchondral cysts.
    Sawa M; Nakasa T; Ikuta Y; Yoshikawa M; Tsuyuguchi Y; Kanemitsu M; Ota Y; Adachi N
    Bone Joint J; 2018 May; 100-B(5):590-595. PubMed ID: 29701088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffuse-Type Tenosynovial Giant Cell Tumor An Update of Current Management Strategies.
    Naja A; Abboud A; Masrouha K; Ghert M; Saghieh S
    Bull Hosp Jt Dis (2013); 2024 Sep; 82(3):178-185. PubMed ID: 39150871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incomplete resection increases the risk of local recurrence and negatively affects functional outcome in patients with tenosynovial giant cell tumor of the hindfoot.
    Tsukamoto S; Zucchini R; Staals EL; Mavrogenis AF; Akahane M; Palmerini E; Errani C; Tanaka Y
    Foot Ankle Surg; 2020 Oct; 26(7):822-827. PubMed ID: 31839476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment, recurrence rates and follow-up of Tenosynovial Giant Cell Tumor (TGCT) of the foot and ankle-A systematic review and meta-analysis.
    Siegel M; Bode L; Südkamp N; Kühle J; Zwingmann J; Schmal H; Herget GW
    PLoS One; 2021; 16(12):e0260795. PubMed ID: 34855875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spinal pigmented villonodular synovitis and tenosynovial giant cell tumor: A report of two cases and a comprehensive systematic review.
    Zeoli T; Mathkour M; Scullen T; Carr C; Abou-Al-Shaar H; Wang L; Divagaran A; Dindial R; Tubbs RS; Bui CJ; Maulucci CM
    Clin Neurol Neurosurg; 2021 Mar; 202():106489. PubMed ID: 33596487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-reported Symptoms of Tenosynovial Giant Cell Tumors.
    Gelhorn HL; Tong S; McQuarrie K; Vernon C; Hanlon J; Maclaine G; Lenderking W; Ye X; Speck RM; Lackman RD; Bukata SV; Healey JH; Keedy VL; Anthony SP; Wagner AJ; Von Hoff DD; Singh AS; Becerra CR; Hsu HH; Lin PS; Tap WD
    Clin Ther; 2016 Apr; 38(4):778-93. PubMed ID: 27041409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of tenosynovial giant cell tumour of the temporomandibular joint: a systematic review.
    Kanbour A; Hurrell M; Ricciardo P
    ANZ J Surg; 2023 Apr; 93(4):869-875. PubMed ID: 37052058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical outcomes of patients with diffuse-type tenosynovial giant-cell tumours: an international, retrospective, cohort study.
    Mastboom MJL; Palmerini E; Verspoor FGM; Rueten-Budde AJ; Stacchiotti S; Staals EL; Schaap GR; Jutte PC; Aston W; Gelderblom H; Leithner A; Dammerer D; Takeuchi A; Thio Q; Niu X; Wunder JS; ; van de Sande MAJ
    Lancet Oncol; 2019 Jun; 20(6):877-886. PubMed ID: 31029509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment updates on tenosynovial giant cell tumor.
    Palmerini E; Staals EL
    Curr Opin Oncol; 2022 Jul; 34(4):322-327. PubMed ID: 35837703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis of Advanced Tenosynovial Giant Cell Tumor of the Knee Diagnosed During Total Knee Arthroplasty.
    Lei P; Sun R; Liu H; Zhu J; Wen T; Hu Y
    J Arthroplasty; 2017 Jun; 32(6):1850-1855. PubMed ID: 28161138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tenosynovial giant cell tumor: case report and review.
    Lucas DR
    Arch Pathol Lab Med; 2012 Aug; 136(8):901-6. PubMed ID: 22849738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of neoadjuvant pexidartinib with limb salvage surgery for diffuse tenosynovial giant cell tumor: A case report.
    Geiger EJ; Jensen AR; Singh AS; Nelson SD; Bernthal NM
    J Orthop Sci; 2024 Jan; 29(1):458-462. PubMed ID: 36402606
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of surgery in tenosynovial giant cell tumours as measured by patient-reported outcomes on quality of life and joint function.
    Verspoor FGM; Mastboom MJL; Hannink G; van der Graaf WTA; van de Sande MAJ; Schreuder HWB
    Bone Joint J; 2019 Mar; 101-B(3):272-280. PubMed ID: 30813787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI identification of pseudolesions in the distal tibia articular surface: Frequency and diagnostic criteria.
    Arndt H; German T; Fischer W; Rehnitz C; Antón Jiménez A; Weber MA
    Eur J Radiol; 2024 Jan; 170():111234. PubMed ID: 38042021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.